Literature DB >> 26523995

An Aggregate of Four Anthrax Cases during the Dry Summer of 2011 in Epirus, Greece.

Georgios Gaitanis1, Christos J Lolis, Antonios Tsartsarakis, Chris Kalogeropoulos, Stamatina Leveidiotou-Stefanou, Aristidis Bartzokas, Ioannis D Bassukas.   

Abstract

BACKGROUND: Human anthrax is currently a sporadic disease in Europe, without significant regional clustering.
OBJECTIVE: To report an unexpected aggregate of anthrax cases and correlate local climatic factors with yearly anthrax admissions.
METHODS: Clinical description of a geographical-temporal anthrax aggregate, correlation of disease admissions with local weather data in the period 2001-2014 and literature reports of anthrax clusters from Europe in the last 20 years.
RESULTS: We identified 5 cases, all cutaneous: an unexpected aggregate of 4 cases in mid-summer 2011 (including a probable human-to-human transmission) and a sporadic case in August 2005, all in relatively dry periods (p < 0.05). Remarkably, 3/6 reports of human anthrax aggregates from Europe were observed in Balkan Peninsula countries in the year 2011.
CONCLUSION: In the light of the predicted climatic change, unexpected anthrax aggregates during dry periods in southern Europe underscore the risk of future anthrax re-emergence on this continent.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26523995     DOI: 10.1159/000440860

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Climatic influence on anthrax suitability in warming northern latitudes.

Authors:  Michael G Walsh; Allard W de Smalen; Siobhan M Mor
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

2.  Control and Prevention of Anthrax, Texas, USA, 2019.

Authors:  Tom Sidwa; Johanna S Salzer; Rita Traxler; Erin Swaney; Marcus L Sims; Pam Bradshaw; Briana J O'Sullivan; Kathy Parker; Kenneth A Waldrup; William A Bower; Kate Hendricks
Journal:  Emerg Infect Dis       Date:  2020-12       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.